Eastman Chemical Company is recommended as a valuable addition to investment portfolios due to its promising revenue and value proposition. Despite a significant sale of shares by The
Gateway Investment Advisors, the chemical domain firm shows potential for sustained earnings consistency, having revealed an expected increase in
EBITDA growth during an investor event. Its Q4 2024 earnings report is highly anticipated by investors, and Bank of America has upgraded its rating to 'Buy'. Notably, 88% of Eastman is held by institutional shareholders, showing significant investor confidence.
Jim Cramer, a highly-regarded investment analyst, has commended Eastman's CEO as intelligent. Furthermore, expectations of future growth due to innovation in circular economy stimuli were highlighted in Eastman's Q3 2024 earnings call. Lastly,
Piper Sandler has issued a pessimistic forecast for Eastman's stock price and there are potential bearish signals due to insider disposition of stock. However, despite these facts, Eastman's powerful financial performance and dividend increase for the 15th year in a row result in a positive outlook for the firm.
Eastman Chemical Company EMN News Analytics from Thu, 07 Mar 2024 08:00:00 GMT to Sat, 18 Jan 2025 13:31:36 GMT -
Rating 8
- Innovation 8
- Rumor 0
